Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Papillomavirus Res. 2016 Dec;2:1–8. doi: 10.1016/j.pvr.2015.10.001

Figure 4.

Figure 4

Figure 4

a. State-level HPV vaccine completion rate among 378, 484 commercially insured females who were aged 9 through 26 years and had at least one claim of HPV vaccination during 2009–2010

b. State-level HPV vaccine dose schedule adherence rate among 111,286 females who completed the 3-dose HPV vaccine series